Brain Cancer Vaccine's Immune Response Key to Outcomes, Cedars-Sinai Study
HealthDay News -- An in-trial dendritic cell vaccine that fights malignant brain tumors called glioblastoma multiforme (GBM) may help boost a patient's immunity response and improve the outcome, a new report says.